James Patrick Kelly, SVP, CFO & Treasurer at Vanda Pharmaceuticals Inc. (VNDA), sold 21,790 shares at $15.51 ($338K) on 2017-01-03, disclosed to the SEC on 2017-01-05.
Open-market sale of $338k VNDA by SVP, CFO & Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.51 | 10,895 | $169K | 50.0% |
| 2 | $15.51 | 10,895 | $169K | 50.0% |
| Total | $15.51 avg | 21,790 | $338K | 100% |
| Filing → |
| VNDA | SELL | 2019-03-04 | $548K | — | Filing → |
| VNDA | SELL | 2019-01-04 | $232K | — | Filing → |
| CBT | SELL | 2018-06-08 | $160K | — | Filing → |